Migdal Insurance & Financial Holdings Ltd. Ab Cellera Biologics Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 02, 2022	SELL	$7.46 - $14.14 $4,438 - $8,413	-595 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$12.99 - $17.73 $7,729 - $10,549	595 New	595 $9,000

Others Institutions Holding ABCL

# of Institutions

155

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

Baker Bros. Advisors LP New York, NY

27.5M
Shares

$77.9 Million
0.76% of portfolio
Baillie Gifford & CO

12.9M
Shares

$36.5 Million
0.03% of portfolio
Voya Investment Management LLC Atlanta, GA

10.6M
Shares

$30.1 Million
0.03% of portfolio
Prosight Management, LP Dallas, TX

9.08M
Shares

$25.7 Million
6.31% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

4.59M
Shares

$13 Million
0.0% of portfolio

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account